Axon Enterprise (AXON) Stock Forecast, Price & News

Axon Enterprise (NASDAQ:AXON) Frequently Asked Questions

Is Axon Enterprise a buy right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Axon Enterprise in the last twelve months. There are currently 1 hold rating, 7 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Axon Enterprise stock.
View analyst ratings for Axon Enterprise or view top-rated stocks.

When is Axon Enterprise's next earnings date?

Axon Enterprise is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Axon Enterprise.

How were Axon Enterprise's earnings last quarter?

Axon Enterprise, Inc. (NASDAQ:AXON) announced its quarterly earnings results on Tuesday, May, 10th. The biotechnology company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.16. The biotechnology company had revenue of $256.43 million for the quarter, compared to the consensus estimate of $233.57 million. Axon Enterprise had a net margin of 4.62% and a trailing twelve-month return on equity of 3.90%. The firm's quarterly revenue was up 31.5% on a year-over-year basis. During the same period last year, the firm posted ($0.75) EPS.
View Axon Enterprise's earnings history.

What guidance has Axon Enterprise issued on next quarter's earnings?

Axon Enterprise issued an update on its FY 2022 earnings guidance on Monday, May, 23rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.05 billion-$1.10 billion, compared to the consensus revenue estimate of $1.05 billion.

What price target have analysts set for AXON?

9 brokers have issued 1 year price targets for Axon Enterprise's shares. Their forecasts range from $120.00 to $232.00. On average, they expect Axon Enterprise's stock price to reach $172.89 in the next twelve months. This suggests a possible upside of 81.1% from the stock's current price.
View analysts' price targets for Axon Enterprise or view top-rated stocks among Wall Street analysts.

Who are Axon Enterprise's key executives?

Axon Enterprise's management team includes the following people:

• Mr. Patrick W. Smith, Co-Founder, CEO & Director (Age 51, Pay $33.12k) (LinkedIn Profile)
• Mr. Luke S. Larson, Pres (Age 41, Pay $828.01k) (LinkedIn Profile)
• Mr. Jawad A. Ahsan, Chief Financial Officer (Age 43, Pay $813.16k) (LinkedIn Profile)
• Mr. Joshua M. Isner, Chief Revenue Officer (Age 36, Pay $2.48M) (LinkedIn Profile)
• Mr. Jeffrey C. Kunins, Chief Product Officer & Exec. VP of Software (Age 47, Pay $753.02k) (LinkedIn Profile)
• Mr. Josh Goldman, Sr. VP of Operations
• Mr. Jim Zito, Sr. VP of Accounting
• Mr. Jenner Holden, Chief Information Security Officer
• Ms. Andrea Susan James, Sr. VP of Investor Relations & Corp. Strategy
• Mr. Isaiah Fields, Corp. Sec. & Gen. Counsel

Who are some of Axon Enterprise's key competitors?

Some companies that are related to Axon Enterprise include Microsoft (MSFT), Oracle (ORCL), ServiceNow (NOW), VMware (VMW), Fortinet (FTNT), Qualys (QLYS), Commvault Systems (CVLT), Progress Software (PRGS), C3.ai (AI) and FalconStor Software (FALC).
View all of AXON's competitors.

What other stocks do shareholders of Axon Enterprise own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axon Enterprise investors own include Novavax (NVAX), NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), (CGC), Micron Technology (MU), TherapeuticsMD (TXMD), ACADIA Pharmaceuticals (ACAD), bluebird bio (BLUE) and Arena Pharmaceuticals (ARNA).

When did Axon Enterprise IPO?

(AXON) raised $251 million in an initial public offering (IPO) on Thursday, June 11th 2015. The company issued 17,900,000 shares at a price of $13.00-$15.00 per share. Jefferies, Evercore ISI and RBC Capital Markets acted as the underwriters for the IPO and JMP Securities and Baird were co-managers.

What is Axon Enterprise's stock symbol?

Axon Enterprise trades on the NASDAQ under the ticker symbol "AXON."

Who are Axon Enterprise's major shareholders?

Axon Enterprise's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (10.73%), Vanguard Group Inc. (8.42%), Baillie Gifford & Co. (5.80%), Capital International Investors (3.75%), State Street Corp (3.13%) and William Blair Investment Management LLC (2.46%). Company insiders that own Axon Enterprise stock include Adriane M Brown, Caitlin Elizabeth Kalinowski, Hadi Partovi, Jawad A Ahsan, Jeffrey C Kunins, Joshua Isner, Julie A Cullivan, Luke Larson, Matthew R Mcbrady, Matthew R Mcbrady and Patrick W Smith.
View institutional ownership trends for Axon Enterprise.

Which major investors are selling Axon Enterprise stock?

AXON stock was sold by a variety of institutional investors in the last quarter, including Lord Abbett & CO. LLC, Baillie Gifford & Co., First Trust Advisors LP, Wellington Management Group LLP, Victory Capital Management Inc., TimesSquare Capital Management LLC, William Blair Investment Management LLC, and Federated Hermes Inc.. Company insiders that have sold Axon Enterprise company stock in the last year include Jawad A Ahsan, Jeffrey C Kunins, Joshua Isner, Julie A Cullivan, Luke Larson, Matthew R Mcbrady, and Patrick W Smith.
View insider buying and selling activity for Axon Enterprise or view top insider-selling stocks.

Which major investors are buying Axon Enterprise stock?

AXON stock was bought by a variety of institutional investors in the last quarter, including Capital International Investors, State Street Corp, BlackRock Inc., Capital Group International Inc. CA , Blair William & Co. IL, J. Goldman & Co LP, Zevenbergen Capital Investments LLC, and Vaughan Nelson Investment Management L.P.. Company insiders that have bought Axon Enterprise stock in the last two years include Adriane M Brown, Caitlin Elizabeth Kalinowski, and Hadi Partovi.
View insider buying and selling activity for Axon Enterprise or or view top insider-buying stocks.

How do I buy shares of Axon Enterprise?

Shares of AXON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Axon Enterprise's stock price today?

One share of AXON stock can currently be purchased for approximately $95.46.

How much money does Axon Enterprise make?

Axon Enterprise has a market capitalization of $6.78 billion and generates $863.38 million in revenue each year. The biotechnology company earns $-60.02 million in net income (profit) each year or $0.519990 on an earnings per share basis.

How many employees does Axon Enterprise have?

Axon Enterprise employs 2,992 workers across the globe.

What is Axon Enterprise's official website?

The official website for Axon Enterprise is www.axovant.com.

How can I contact Axon Enterprise?

Axon Enterprise's mailing address is 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS. The biotechnology company can be reached via phone at (480) 991-0797, via email at [email protected], or via fax at 480-991-0791.